Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab, capecitabine and radiotherapy as neoadjuvant treatment for locally advanced resectable rectal cancer
2006-001371-38Phase 2Completed
- Sponsor
- Institute of Oncology Ljubljana
- Start
- Aug 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cetuximab in rectal cancer, sponsored by Institute of Oncology Ljubljana. Primary endpoint: Pathological complete response rate. Started Aug 2006; status: completed.
02
Drugs
cetuximab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on 2006-001371-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001371-38.